AustraliaWorld Eisai Says Alzheimer’s Drug Will Get Priority Review in UnitedStates By australianadmin July 6, 2022July 6, 2022 0 minutes, 7 seconds Read Eisai Co. stated its speculative Alzheimer’s drug lecanemab will get a concern evaluation by the U.S. Food and Drug Administration.Read More.
World On this day: Boston Celtics beat Utah Jazz without making a 3-tip By Romeo Peter December 21, 2022December 21, 2022
World What a win or loss would imply for the Commanders in the 2023 NFL draft order By Romeo Peter January 7, 2023January 7, 2023